Comorbidities in ADHD children treated with methylphenidate: a database study (Q34538107)

2 August 2017

Comorbidities in ADHD children treated with methylphenidate: a database study (English)

1 reference

2 August 2017

0 references

1 reference

4

0 references

Rafael Mikolajczyk

object named as

Rafael T Mikolajczyk

7

0 references

author name string

Angela A Kraut

1

1 reference

2 August 2017

Ingo Langner

2

1 reference

2 August 2017

Christina Lindemann

3

1 reference

2 August 2017

Ulrike Petermann

5

1 reference

2 August 2017

Franz Petermann

6

1 reference

2 August 2017

Edeltraut Garbe

8

1 reference

2 August 2017

7 January 2013

1 reference

2 August 2017

1 reference

2 August 2017

13

1 reference

2 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-244x-13-11

2 August 2017

0 references

cites work

Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

ADHD drugs and serious cardiovascular events in children and young adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

Developmental comorbidity in attention-deficit/hyperactivity disorder

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

Narcolepsy in adolescents

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

European guidelines on managing adverse effects of medication for ADHD.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

Very early predictors of adolescent depression and suicide attempts in children with attention-deficit/hyperactivity disorder

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

Safety of stimulant treatment in attention deficit hyperactivity disorder: part II.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

Psychotropic drug use among Icelandic children: a nationwide population-based study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

Developmental psychopathology: Attention Deficit Hyperactivity Disorder (ADHD).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

ADHD characteristics: I. Concurrent co-morbidity patterns in children & adolescents

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

Prevalence of methylphenidate use among Israeli children: 1998-2004.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

ADHD drugs and cardiovascular risk

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

The CBCL as a screen for psychiatric comorbidity in paediatric patients with ADHD.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

The effect of chronic or intermittent hypoxia on cognition in childhood: a review of the evidence

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

Co-existing disorders in ADHD -- implications for diagnosis and intervention

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

The use of methylphenidate in children: analysis of prescription usage based in routine data of the statutory health insurance bodies concerning drug prescriptions

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

ADHD comorbidity findings from the MTA study: comparing comorbid subgroups

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

Attention-deficit/hyperactivity disorder and comorbidity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

Safety issues in the use of methylphenidate. An American perspective

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

Prevalence and patterns of methylphenidate use in French children and adolescents

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-11

Trends in incidence and characteristics of children, adolescents, and adults initiating immediate- or extended-release methylphenidate or atomoxetine in the Netherlands during 2001-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-11

Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-11

Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-11

New insights into the comorbidity between ADHD and major depression in adolescent and young adult females

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-11

The comorbidity of ADHD in the general population of Swedish school-age children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-11

Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-11

Congenital heart disease in the general population: changing prevalence and age distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-11

Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-11

Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-11

ADORE -- Attention-Deficit Hyperactivity Disorder Observational Research in Europe.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

European clinical guidelines for hyperkinetic disorder -- first upgrade

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544568

Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in

27 October 2018

1 reference

12 December 2020

[The prevalence of attention-deficit/hyperactivity disorder (ADHD) among children and adolescents in Germany. Initial results from the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)]

1 reference

12 December 2020

Thyroid hormones correlate with symptoms of hyperactivity but not inattention in attention deficit hyperactivity disorder

1 reference

12 December 2020

ADHD and Thyroid Abnormalities: A Research Note

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-244X-13-11

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference